Phenotypic Analysis of Antigen-Specific T Lymphocytes

Identification and characterization of antigen-specific T lymphocytes during the course of an immune response is tedious and indirect. To address this problem, the peptide-major histocompatability complex (MHC) ligand for a given population of T cells was multimerized to make soluble peptide-MHC tetramers. Tetramers of human lymphocyte antigen A2 that were complexed with two different human immunodeficiency virus (HIV)-derived peptides or with a peptide derived from influenza A matrix protein bound to peptide-specific cytotoxic T cells in vitro and to T cells from the blood of HIV-infected individuals. In general, tetramer binding correlated well with cytotoxicity assays. This approach should be useful in the analysis of T cells specific for infectious agents, tumors, and autoantigens.

[1]  Franciscus Kroese,et al.  The handbook of experimental immunology. , 1997 .

[2]  R. Welsh,et al.  Reduction of otherwise remarkably stable virus-specific cytotoxic T lymphocyte memory by heterologous viral infections , 1996, The Journal of experimental medicine.

[3]  P. Doherty,et al.  Establishment and Persistence of Virus‐Specific CD4+ and CD8+ T Cell Memory , 1996, Immunological reviews.

[4]  H. Pircher,et al.  Visualization, characterization, and turnover of CD8+ memory T cells in virus-infected hosts , 1996, The Journal of experimental medicine.

[5]  D. Farber,et al.  The extracellular domain of CD45 controls association with the CD4-T cell receptor complex and the response to antigen-specific stimulation , 1996, The Journal of experimental medicine.

[6]  H. Macdonald,et al.  Distinct phenotypes of antigen-selected CD8 T cells emerge at different stages of an in vivo immune response. , 1995, Journal of immunology.

[7]  P. Doherty,et al.  Prevalence and activation phenotype of Sendai virus-specific CD4+ T cells. , 1995, Virology.

[8]  S. Rowland-Jones,et al.  Persistent high frequency of human immunodeficiency virus-specific cytotoxic T cells in peripheral blood of infected donors. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[9]  P. Doherty,et al.  Temporal loss of the activated L-selectin-low phenotype for virus-specific CD8+ memory T cells. , 1995, Journal of immunology.

[10]  M. Davis,et al.  Antigen-specific development of primary and memory T cells in vivo. , 1995, Science.

[11]  J. Bell,et al.  Human HLA-A0201-restricted cytotoxic T lymphocyte recognition of influenza A is dominated by T cells bearing the V beta 17 gene segment , 1995, The Journal of experimental medicine.

[12]  H. von Boehmer,et al.  On the cellular basis of immunological T cell memory. , 1995, Immunity.

[13]  M. Davis,et al.  Kinetics of T-cell receptor binding to peptide/I-Ek complexes: correlation of the dissociation rate with T-cell responsiveness. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[14]  Young Sang Kim,et al.  T cell receptor-MHC class I peptide interactions: affinity, kinetics, and specificity. , 1994, Science.

[15]  R. J. Cohen,et al.  Kinetics and affinity of reactions between an antigen-specific T cell receptor and peptide-MHC complexes. , 1994, Immunity.

[16]  P. Schatz.  Use of Peptide Libraries to Map the Substrate Specificity of a Peptide-Modifying Enzyme: A 13 Residue Consensus Peptide Specifies Biotinylation in Escherichia coli , 1993, Bio/Technology.

[17]  P. Doherty,et al.  Partitioning of responder CD8+ T cells in lymph node and lung of mice with Sendai virus pneumonia by LECAM-1 and CD45RB phenotype. , 1993, Journal of immunology.

[18]  C. Parish,et al.  Detection of a glycosylation-dependent ligand for the T lymphocyte cell adhesion molecule CD2 using a novel multimeric recombinant CD2-binding assay. , 1993, Journal of immunology.

[19]  J. Casanova,et al.  Oligoclonal expansion of major histocompatibility complex class I- restricted cytolytic T lymphocytes during a primary immune response in vivo: direct monitoring by flow cytometry and polymerase chain reaction , 1993, The Journal of experimental medicine.

[20]  R. Locksley,et al.  TH1 and TH2 cell antigen receptors in experimental leishmaniasis. , 1993, Science.

[21]  X. Jin,et al.  Quantitative analysis of the human immunodeficiency virus type 1 (HIV- 1)-specific cytotoxic T lymphocyte (CTL) response at different stages of HIV-1 infection: differential CTL responses to HIV-1 and Epstein- Barr virus in late disease , 1993, The Journal of experimental medicine.

[22]  D. Wiley,et al.  HLA-A2-peptide complexes: refolding and crystallization of molecules expressed in Escherichia coli and complexed with single antigenic peptides. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[23]  B. Walker,et al.  An optimal viral peptide recognized by CD8+ T cells binds very tightly to the restricting class I major histocompatibility complex protein on intact cells but not to the purified class I protein. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[24]  R. Koup,et al.  Limiting dilution analysis of cytotoxic T lymphocytes to human immunodeficiency virus gag antigens in infected persons: in vitro quantitation of effector cell populations with p17 and p24 specificities , 1991, The Journal of experimental medicine.

[25]  B. Walker,et al.  HIV-1 gag-specific cytotoxic T lymphocytes recognize multiple highly conserved epitopes. Fine specificity of the gag-specific response defined by using unstimulated peripheral blood mononuclear cells and cloned effector cells. , 1991, Journal of immunology.

[26]  G. Nossal,et al.  Molecular characterization of single memory B cells , 1991, Nature.

[27]  D. Nixon,et al.  High frequency of memory and effector gag specific cytotoxic T lymphocytes in HIV seropositive individuals. , 1990, International immunology.

[28]  M. Baseler,et al.  Defective clonogenic potential of CD8+ T lymphocytes in patients with AIDS. Expansion in vivo of a nonclonogenic CD3+CD8+DR+CD25- T cell population. , 1990, Journal of immunology.

[29]  B. Autran,et al.  Unusually high frequencies of HIV-specific cytotoxic T lymphocytes in humans. , 1989, Journal of immunology.

[30]  D. Nixon,et al.  HIV-1 gag-specific cytotoxic T lymphocytes defined with recombinant vaccinia virus and synthetic peptides , 1988, Nature.

[31]  B. Walker,et al.  HIV-1 reverse transcriptase is a target for cytotoxic T lymphocytes in infected individuals. , 1988, Science.

[32]  R. Hardy,et al.  Isolation of high-affinity memory B cells: phycoerythrin as a probe for antigen-binding cells. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[33]  O. Majdic,et al.  Kinetics of activation antigen expression by in vitro-stimulated human T lymphocytes. , 1985, Cellular immunology.

[34]  T. Taniyama,et al.  In vitro induction of T-lymphocyte-mediated cytotoxicity by infectious murine type C oncornaviruses , 1979, The Journal of experimental medicine.

[35]  R. Winchester,et al.  Ia determinants on stimulated human T lymphocytes. Occurrence on mitogen- and antigen-activated T cells , 1979, The Journal of experimental medicine.

[36]  L A Herzenberg,et al.  Demonstration that antigen-binding cells are precursors of antibody-producing cells after purification with a fluorescence-activated cell sorter. , 1972, Proceedings of the National Academy of Sciences of the United States of America.